Epigenetic alterations in autoimmune rheumatic diseases.

Area of Science:

• Rheumatology
• Epigenetics
• Immunology

Background:

• Epigenetic alterations, particularly DNA methylation, are increasingly recognized for their role in autoimmune rheumatic diseases.
• These mechanisms link environmental factors and genetic predispositions, offering insights into disease pathogenesis.
• Evidence suggests altered DNA methylation patterns are present in conditions like systemic lupus erythematosus (SLE) and rheumatoid arthritis.

Purpose of the Study:

• To discuss the proposed mechanisms and implications of DNA methylation changes in autoimmune rheumatic diseases.
• To explore the prospects for future epigenetic studies in rheumatology.
• To highlight the relevance of specific DNA methylation markers and epigenetic drugs in clinical management.

Main Methods:

• Review of existing literature on epigenetic alterations in autoimmune rheumatic diseases.
• Analysis of studies examining DNA methylation patterns in diseases such as SLE and rheumatoid arthritis.
• Consideration of twin studies to exclude genetic variability as a cause of disease discordance.

Main Results:

• DNA methylation patterns are altered in autoimmune rheumatic diseases, contributing to their pathogenesis.
• Tissue-specificity of DNA methylation changes is a critical factor to consider in epigenetic research.
• Monozygotic twin studies demonstrate the role of epigenetic changes independent of genetic factors.

Conclusions:

• DNA methylation plays a significant role in the pathogenesis of autoimmune rheumatic diseases.
• Epigenetic markers hold promise for diagnostics and therapeutics in rheumatology.
• Epigenetic drugs may offer novel treatment strategies for patients with rheumatic diseases.